Vivos Therapeutics Enters Material Definitive Agreement
Ticker: VVOS · Form: 8-K · Filed: Apr 17, 2025 · CIK: 1716166
| Field | Detail |
|---|---|
| Company | Vivos Therapeutics, Inc. (VVOS) |
| Form Type | 8-K |
| Filed Date | Apr 17, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-definitive-agreement
TL;DR
Vivos Therapeutics signed a big deal on April 15th, 8-K filed today.
AI Summary
Vivos Therapeutics, Inc. announced on April 17, 2025, that it entered into a Material Definitive Agreement on April 15, 2025. The filing details are provided in an 8-K report.
Why It Matters
This filing indicates a significant new agreement for Vivos Therapeutics, which could impact its business operations and future financial performance.
Risk Assessment
Risk Level: medium — Entering into a material definitive agreement is a significant event that could carry substantial implications, both positive and negative, for the company.
Key Players & Entities
- Vivos Therapeutics, Inc. (company) — Registrant
- April 17, 2025 (date) — Date of Report
- April 15, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-39796 (commission_file_number) — SEC File Number
- 81-3224056 (ein) — IRS Employer Identification No.
- 7921 Southpark Plaza, Suite 210 (address) — Principal executive offices
- Littleton, Colorado 80120 (address) — Principal executive offices
- (844) 672-4357 (phone_number) — Registrant's telephone number
FAQ
What type of material definitive agreement did Vivos Therapeutics enter into?
The filing states that Vivos Therapeutics, Inc. entered into a Material Definitive Agreement on April 15, 2025, but the specific details of the agreement are not provided in this excerpt.
When was this 8-K filing submitted to the SEC?
This 8-K filing was submitted on April 17, 2025.
What is Vivos Therapeutics, Inc.'s principal executive office address?
Vivos Therapeutics, Inc.'s principal executive offices are located at 7921 Southpark Plaza, Suite 210, Littleton, Colorado 80120.
What is the SEC file number for Vivos Therapeutics, Inc.?
The SEC file number for Vivos Therapeutics, Inc. is 001-39796.
What is the IRS Employer Identification Number for Vivos Therapeutics, Inc.?
The IRS Employer Identification Number for Vivos Therapeutics, Inc. is 81-3224056.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 17, 2025 regarding Vivos Therapeutics, Inc. (VVOS).